MicroPort NeuroTech's revenue for the
six
months ended in Dec. 2023 was HK$400.8 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$728.0 Mil.
MicroPort NeuroTech's Revenue per Share for the
six
months ended in Dec. 2023 was HK$0.69.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.25.
During the past 5 years, MicroPort NeuroTech's highest 3-Year average Revenue per Share Growth Rate was 49.80% per year. The lowest was 40.40% per year. And the median was 45.10% per year.
MicroPort NeuroTech Revenue Historical Data
The historical data trend for MicroPort NeuroTech's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MicroPort NeuroTech's Revenue
For the Medical Devices subindustry, MicroPort NeuroTech's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort NeuroTech's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroTech's Revenue distribution charts can be found below:
* The bar in red indicates where MicroPort NeuroTech's Revenue falls into.
MicroPort NeuroTech Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$728.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
MicroPort NeuroTech Revenue Related Terms
Thank you for viewing the detailed overview of MicroPort NeuroTech's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
MicroPort NeuroTech (HKSE:02172) Business Description
MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02172 has been successfully added to your